Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive Chemotherapy (BET) For Selected Categories Of Malignant Central Nervous System Tumor
NCT00007982Phase 2Completed
- Sponsor
- Herbert Irving Comprehensive Cancer Center
- Start
- Apr 1999
- Primary completion
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carmustine, etoposide, thiotepa in central nervous system tumor, head and neck cancer (HNC), lymphoma, sponsored by Herbert Irving Comprehensive Cancer Center. Started Apr 1999; status: completed.
02
Drugs
carmustineetoposidethiotepa
03
Conditions
central nervous system tumorhead and neck cancer (HNC)lymphoma
Beyond the preview
Go deeper on NCT00007982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007982.